Necrotizing Fasciitis / Fournier's Gangrene
Fournier's gangrene (FG) is a rapidly progressive, polymicrobial necrotizing fasciitis of the perineum, genitalia, and perianal region constituting a true surgical emergency. Despite its recognition as a distinct entity since Jean-Alfred Fournier's 1883 description, FG represents type I necrotizing soft tissue infection (NSTI) and should be conceptualized within that broader framework. Population-based mortality in contemporary series is approximately 7.5%, though single-center tertiary referral series report 20–40%, and mortality exceeds 70% in the setting of septic shock.[1][2] Survival depends entirely on early recognition, aggressive and repeated surgical debridement, and broad-spectrum antimicrobial therapy — with modern series shifting toward skin-sparing debridement techniques that markedly improve reconstruction options without increasing mortality.
Epidemiology
- Incidence: ~1.6 per 100,000 males; approximately 0.02% of all hospital admissions[2]
- Predominantly affects ages 50–79 years
- Female cases represent 20–30% of all FG; female mortality (~7.1%) is slightly higher than male (~5.7%)[2][3]
- High-volume centers demonstrate comparable mortality to low-volume centers despite treating more severe disease, suggesting a possible center-effect for optimal multidisciplinary management[2]
- Nearly 50% of patients with FG seek prior medical care for the same symptoms before the NSTI diagnosis is made — indicating a frequent window for earlier diagnosis[2]
Pathophysiology
FG originates from synergistic polymicrobial infection exploiting fascial planes with devastating speed. Common source sites include:
- Anorectal: anorectal abscess, anal fistula, rectal perforation
- Urogenital: urethral stricture, periurethral abscess, catheter trauma, urinary extravasation
- Cutaneous: trauma, pressure ulcer, surgical wound
The hallmark is obliterative endarteritis of subcutaneous vessels causing ischemic fascial necrosis with gas production, spreading rapidly along Colles', Scarpa's, and Dartos fascial planes. A critical insight with implications for surgical technique: the rich and redundant vasculature of the skin means cutaneous manifestations may appear much later than deep tissue necrosis — intact overlying skin may overlie extensively necrotic subcutaneous tissue, yet remain histologically viable and salvageable.[2][4] This underpins the modern skin-sparing surgical approach.
The Dartos fascia is relatively resistant to spread of infection into the testicular blood supply (which arises directly from the aorta via the testicular arteries), explaining why testicular salvage is usually possible despite extensive scrotal involvement.
Microbiology
FG is polymicrobial in ~58% of cases; monomicrobial infection is documented in ~30%.[2] Mixed aerobic-anaerobic synergism is the rule, but the strict framing of FG as "invariably polymicrobial" is an overstatement.
| Category | Common Organisms |
|---|---|
| Aerobic gram-positive | Staphylococcus aureus (including MRSA), Streptococcus spp. (Group A), Enterococcus faecium |
| Aerobic gram-negative | Escherichia coli (most frequent overall), Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus spp. |
| Anaerobic | Bacteroides fragilis, Fusobacterium spp., Clostridium spp., Peptostreptococcus spp. |
:::note Higher Mortality Organisms MRSA and Acinetobacter are independently associated with higher mortality in FG. Culture results should prompt early de-escalation or targeted therapy as sensitivities return.[2] :::
Risk Factors
| Category | Risk Factors |
|---|---|
| Metabolic | Diabetes mellitus (most common — 40–70% of cases), obesity, malnutrition |
| Immunosuppression | HIV/AIDS, malignancy, corticosteroids, chemotherapy, organ transplant |
| Vascular | Peripheral vascular disease, chronic venous insufficiency |
| Local predisposing | Urethral stricture, perianal abscess, anorectal fistula, urinary instrumentation, trauma |
| Behavioral | Alcohol use disorder, intravenous drug use |
| Novel | Sarcopenia (independent risk factor for mortality)[2] |
| Medication | SGLT-2 inhibitors (empagliflozin, canagliflozin, dapagliflozin) carry an FDA 2018 safety alert; however, subsequent high-level evidence has not demonstrated a significant difference in FG incidence between SGLT-2 inhibitors and other diabetes treatments[2][5] |
Clinical Presentation and Diagnosis
Clinical Features
Early FG may be mistaken for cellulitis or scrotal abscess. Progression to frank necrosis can occur within hours.
Early: Perineal/scrotal erythema, pain, and edema out of proportion to visible skin changes; induration; fever, tachycardia
Late: Gray/bronze/violaceous skin discoloration with blistering; crepitus on palpation; foul-smelling discharge; cutaneous gangrene; septic shock
:::warning Operate on Clinical Diagnosis — Do Not Wait for Imaging The clinical diagnosis of FG is made at the bedside. Do not delay operative debridement in a patient with systemic sepsis and perineal crepitus or necrosis. CT is valuable for delineating extent and identifying source in equivocal cases but must never delay surgery in an obvious presentation.[1] :::
Imaging
| Modality | Performance | Notes |
|---|---|---|
| CT abdomen/pelvis with IV contrast | Sensitivity 100%, Specificity 98% — gold standard[2] | Subcutaneous gas = pathognomonic; identifies fascial plane fluid and source |
| Point-of-care ultrasound | Real-time; operator-dependent | May identify superficial collections; limited deep fascial assessment |
| MRI | Superior soft tissue characterization | Slow acquisition limits emergency use; impractical in unstable patients |
| Plain radiograph | Low sensitivity | May detect gross subcutaneous gas; insufficient for planning |
Severity Scoring
Fournier's Gangrene Severity Index (FGSI)
Developed by Laor et al. (1995);[6] uses 9 physiological parameters scored 0–4 based on deviation from normal:
| Variable | Abnormal Deviation | Max Points |
|---|---|---|
| Temperature (°C) | ≥41 or <30 | 4 |
| Heart rate (bpm) | ≥180 or <40 | 4 |
| Respiratory rate | ≥50 or <6 | 4 |
| Serum sodium (mEq/L) | ≥160 or <111 | 4 |
| Serum creatinine (mg/dL) | >3.5 | 4 |
| Serum potassium (mEq/L) | ≥7.0 or <2.5 | 4 |
| Hematocrit (%) | ≥60 or <20 | 4 |
| WBC (×1,000/mm³) | ≥40 or <1 | 4 |
| Serum bicarbonate (mEq/L) | <15 | 4 |
FGSI ≤9 → ~75% survival probability; FGSI >9 → ~75% mortality probability (original series)
Uludag FGSI (UFGSI) — Higher Predictive Accuracy
Developed in 2010; incorporates age and disease extent in addition to FGSI parameters.[2]
- Score >9: 94% mortality probability
- Score ≤9: 81% survival probability
- AUC: 0.94 — highest predictive performance of available scoring tools
Simplified FGSI (SFGSI)
Uses only potassium, creatinine, and hematocrit — more practical in time-sensitive settings.[2]
- AUC: 0.84; maintains clinically useful predictive accuracy with fewer variables
CRP Ratio as Mortality Predictor
Mean CRP ratio (follow-up / initial) differs significantly between survivors (6.7 ± 6.6) and non-survivors (1.2 ± 0.8); a CRP ratio cutoff of 1.78 predicts death with 86% sensitivity and 82% specificity.[2] Rising CRP over the first 48–72 hours of treatment indicates inadequate source control and should prompt early return to the OR.
LRINEC Score
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) incorporates WBC, CRP, hemoglobin, sodium, creatinine, and glucose.[7] Score ≥6 has ~68% sensitivity and ~85% specificity for NSTI. A negative LRINEC does not exclude NSTI.
:::note Scores Are Prognostic — Not Decision Tools All scoring systems provide prognostic information and can guide ICU communication and family counseling. They must never delay or defer operative intervention in a clinically apparent or deteriorating patient. :::
Surgical Management
Timing
Emergency surgical debridement is the single most important determinant of survival. Each hour of delay worsens outcomes.[8] Simultaneous resuscitation (IV fluids, vasopressors if required, blood products) is initiated in parallel with operative preparation — resuscitation does not precede surgery.
Skin-Sparing Debridement — Modern Paradigm
Historical radical debridement excised all tissue through to healthy, non-cellulitic margins, often sacrificing viable skin and creating large defects requiring complex reconstruction. Contemporary evidence supports a skin-sparing approach: because the rich cutaneous vasculature may preserve skin viability even over necrotic subcutaneous tissue, the emphasis is on excising only dead or severely compromised tissue.[2][4]
Tom et al. (n = 487 patients) comparing traditional (n = 230) vs. skin-sparing debridement (n = 257):[4]
- Mortality: Comparable between groups
- Primary closure rates: 0% (traditional) → 50% (skin-sparing)
- Complex reconstructions: Markedly reduced with skin-sparing
This data fundamentally changed the reconstructive landscape for FG — primary delayed closure is now achievable in half of patients.
Operative Technique
Positioning: Lithotomy for wide perineal, scrotal, and genital exposure
Incision strategy: Long incisions approximately 2 cm medial to the inguinal crease, extending toward the anterior superior iliac spine and gluteal region. Incisions are extended liberally for visualization; excision is reserved only for demonstrably necrotic tissue.
Blunt dissection distinguishes healthy from necrotic planes. Healthy tissue bleeds briskly; necrotic tissue does not. The finger test — finger dissection proceeds through normally adherent fascial planes without resistance — confirms NSTI.
Wound left open after debridement — never close at initial operation.
Extent of debridement:
- All visibly necrotic skin, subcutaneous tissue, and fascia
- Extend along fascial planes to bleeding margins
- Scrotum: Orchiectomy rarely required — testicular blood supply is preserved through spermatic cord
- Penis: Debride necrotic Dartos and Buck's fascia; penectomy very rarely required
- Perineum/perirectal: May extend to ischiorectal fossa; consider loop colostomy when anorectal source is identified, perirectal involvement is extensive, or stool contamination threatens wound healing
- Urinary diversion: SPT recommended when extensive perineal involvement is present or urethral injury has occurred
:::note Re-Look Operations Are Mandatory Systematic planned re-look debridement every 24–48 hours until the wound is clean with no residual necrosis.[8] Median number of debridements: 1.8–3.5 in reported series; complex cases require more. Areas appearing viable at initial debridement may become ischemic within 24–72 hours post-mobilization. Inadequate single-operation approaches are associated with increased mortality — re-look is not a sign of incomplete initial surgery, it reflects the evolving biology of the disease. :::
Antimicrobial Therapy
Broad-spectrum empiric antibiotics must be initiated immediately upon diagnosis:[9]
Standard polymicrobial coverage options (IDSA-based):
| Regimen | Components |
|---|---|
| Option 1 | Linezolid + Piperacillin-tazobactam |
| Option 2 | Vancomycin + Clindamycin + Piperacillin-tazobactam |
| Option 3 (PCN allergy) | Linezolid + Meropenem; or Linezolid + Cefepime/Ceftriaxone + Metronidazole |
| Critically ill (broad) | Carbapenem monotherapy (meropenem or imipenem-cilastatin) |
Clindamycin and linezolid have anti-toxin activity (inhibit bacterial protein synthesis) — particularly important in Group A streptococcal NSTI.
De-escalate antibiotics based on intraoperative wound cultures (obtain at initial debridement). Continue until systemic infection has resolved, wounds are clean, and the patient is hemodynamically stable — typically 7–14 days after source control.
Adjunct and Investigational Therapies
| Therapy | Evidence | Recommendation |
|---|---|---|
| Hyperbaric oxygen (HBO) | Controversial; some studies suggest mortality benefit, others no benefit; RCT data lacking | May be considered as adjunct at centers with HBO capability; never delays surgery |
| IVIG | Supports benefit in invasive Group A streptococcal infection; no significant mortality benefit demonstrated for broader FG pathogen spectrum[2] | Not recommended routinely |
| Reltecimod | 2020 trial showed promising trends but no significant benefit in modified intent-to-treat analysis; FDA unapproved[2] | Investigational; not standard of care |
Wound Management
After each debridement:[10]
- Dakin's solution (dilute sodium hypochlorite, in use since 1915) — bactericidal with fibroblast recruitment activity; dilute concentrations minimize cytotoxicity while maintaining antibacterial effect
- Hypochlorous acid-based solutions (e.g., Vashe®, PhaseOne®) — effective against bacterial biofilms, sterilizing most within 10 minutes; further comparative evidence needed[2]
- Negative pressure wound therapy (NPWT/VAC): minimizes dressing changes, reduces pain, increases mobility, optimizes wounds for reconstruction; evidence for mortality impact is equivocal but NPWT remains standard at high-volume centers given the complexity of perineal anatomy[2][10]
- Exteriorized testicles can be placed in subcutaneous thigh pouches as temporary measure when scrotal reconstruction is deferred
Reconstruction
Reconstruction is deferred until infection has resolved, wound is clean with healthy granulation, and systemic illness has cleared — typically 2–4 weeks after the final debridement.[1]
A systematic review of 38 studies and 576 reconstructions found:[2][11]
- 77.6% used simpler techniques (direct closure, secondary healing, skin grafts, local flaps)
- 22.4% required complex loco-regional flaps
- No free flaps reported in the FG reconstruction literature
| Wound Extent | Preferred Option |
|---|---|
| Small defects | Secondary intention or delayed primary closure (modern preference) |
| Moderate scrotal defects | Split-thickness skin graft (STSG) — preferred over FTSG for take rate |
| Large scrotal / perineal defects | STSG; gracilis myocutaneous flap for deep perineal floor defects |
| Complex loco-regional needs | Anterolateral thigh, superomedial thigh, groin, SCIP, or Limberg transposition flap |
| Extensive scrotal loss with exteriorized testicles | Thigh pouch; eventual flap reconstruction when conditions allow |
| Penile shaft skin loss | STSG over corporal bodies |
:::note Delayed Primary Closure — Modern Preference With skin-sparing debridement, delayed primary closure is achievable in ~50% of patients (Tom et al.).[4] Sandberg et al. (2022) demonstrated delayed primary closure decreases wound convalescence by >60% compared to secondary intention, with preliminary cost savings when outpatient care is accounted for.
Tissue expanders are contraindicated in the setting of complete scrotal loss. Testicular thigh pouches, while simple to perform, carry concerns about temperature regulation and testicular function — patient preference for reconstruction approach should be elicited. :::
Colostomy reversal (when performed) is typically planned at 3–6 months after the index operation once complete recovery is confirmed.
:::note Patient-Reported Outcomes There are currently no studies employing validated patient-reported outcome measures after genital reconstruction for FG. Functional and satisfaction data are critically lacking despite the profound impact on genital anatomy and body image. This represents a major gap in the literature.[2] :::
References
1. American College of Surgeons Trauma Quality Programs. ACS TQP Best Practices Guidelines: Management of Genitourinary Injuries. Chicago, IL; August 2025. Available at: facs.org/cot
2. Kopechek KJ, Patel HV, Koch GE. Modern Management of Fournier's Gangrene. Curr Urol Rep. 2025;26(1):47. PMID 40257609 doi:10.1007/s11934-025-01275-3
3. Abbasi R, et al. New insights on female morbidity and mortality disparities in Fournier's gangrene. 2025. [As cited in Kopechek et al. 2025]
4. Tom J, et al. Skin-sparing debridement of Fournier's gangrene: A multi-institutional retrospective study (n=487). eScholarship / UC. Available at: escholarship.org/uc/item/79r088kf [As cited in Kopechek et al. 2025 — primary closure 50% vs 0% with traditional approach; comparable mortality]
5. US Food and Drug Administration. FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes. FDA Drug Safety Communication. August 29, 2018.
6. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol. 1995;154(1):89–92. PMID 7539860
7. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–1541. PMID 15241098
8. Sorensen MD, Krieger JN, Rivara FP, et al. Fournier's Gangrene: Management and mortality predictors in a population based study. J Urol. 2009;182(6):2742–2747. PMID 19836775
9. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the IDSA. Clin Infect Dis. 2014;59(2):e10–52. PMID 24973422
10. Czymek R, Schmidt A, Eckmann C, et al. Fournier's gangrene: Vacuum-assisted closure versus conventional dressings. Am J Surg. 2009;197(2):168–176. PMID 18359406
11. Susini L, et al. Systematic review of reconstructive strategies after Fournier's gangrene (38 studies, 576 reconstructions). [As cited in Kopechek et al. 2025]